Abstract
Research Overview
This Frost & Sullivan research service entitled U.S. Intranasal Drug Delivery
Market provides pipeline analysis, forecasts and technology overviews. In
this research, Frost & Sullivan's expert analysts thoroughly examine the
following markets: allergy, osteoporosis, pain management, vaccines and sexual
dysfunction.
This analysis is available through our Pharmaceutical Growth Partnership
Services program. With this program, clients receive industry-leading market
research such as this, along with technical and econometric data and many
interactive features including Analyst Inquiry Time and Client Councils. For
more information on this custom subscription service, please click here.
What's Included
- ・Pipeline Analysis
- ・Market Forecasts
- ・Technology Overviews
Market Sectors
・Allergy ・Pain Management ・Osteoporosis ・Vaccines ・Sexual Dysfunction
Market Overview
The intranasal drug delivery market is undergoing a fundamental change,
shifting from topical to systemic delivered drugs. The last several years have
seen allergy corticosteroids dominate the intranasal delivery market but new
products in pain management, osteoporosis, vaccines and sexual dysfunction are
expected to drive growth and prove systemic drug delivery is the future of
revenue generation for this market. New drug delivery technologies and
devices are paving the way for peptides and large molecules to be delivered
via the nose.
The intranasal drug delivery market is expected to expand the current
offerings of drugs in key disease areas such as pain management and
osteoporosis. Reformulation of injection and oral drugs is expected to drive
these markets forward be offering an enhanced delivery method with fast onset
of action. The sexual dysfunction market is expected to bring in substantial
revenue as a first in class drug offering a choice for those suffering from
sexual dysfunction in both males and females.
View Cart
